ARAY.NASDAQAccuray INC

SCHEDULE: TCW Group Boosts Accuray Stake via New Warrants

Sentiment:

Amendment to Beneficial Ownership Statement


TCW Group, Inc. has increased its beneficial ownership in Accuray Inc. to 11.5% through the issuance of new common stock purchase warrants.

Capital raiseAccuray Inc. issued new Common Stock Purchase Warrants to TCW Rescue Financing and TCW Direct Lending on December 15, 2025.These warrants were issued in connection with amendments to the Financing Agreement, serving as an incentive for the lenders to agree to the amendments.The warrants include December Premium Warrants (1,034,592 shares to TCW Rescue Financing and 77,469 shares to TCW Direct Lending, exercisable at $1.25 per share).Super Premium Warrants (1,448,429 shares to TCW Rescue Financing and 108,457 shares to TCW Direct Lending, exercisable at $1.50 per share).December Penny Warrants (827,673 shares to TCW Rescue Financing and 61,975 shares to TCW Direct Lending, exercisable at $0.01 per share).No separate consideration was paid for these December Warrants; any exercise price would be paid using working capital funds.

Summary

  • The TCW Group, Inc. has filed an amendment to its Schedule 13D, disclosing an increase in its beneficial ownership of Accuray Inc. common stock to 11.5%, representing 15,467,952 shares.
  • This increase is primarily due to the issuance of new common stock purchase warrants on December 15, 2025, to TCW Rescue Financing and TCW Direct Lending.
  • These warrants were issued without separate consideration, serving as an incentive for the holders to agree to amendments to the existing Financing Agreement.
  • The newly issued warrants include December Premium Warrants (1,112,061 shares at $1.25/share), Super Premium Warrants (1,556,886 shares at $1.50/share), and December Penny Warrants (889,648 shares at $0.01/share).
  • All December Warrants are exercisable on or after December 15, 2025 (Penny Warrants) or six months and one day after December 15, 2025 (Premium and Super Premium Warrants), and all expire on December 15, 2032.
  • The calculation of the 11.5% beneficial ownership is based on 118,782,630 shares of Common Stock outstanding as of January 30, 2026, plus the 15,467,952 shares issuable upon exercise of all Warrants (including previously issued June Warrants).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development. While securing amendments to a financing agreement is positive, the issuance of warrants without separate consideration as an incentive suggests Accuray may have been in a less favorable negotiating position, potentially indicating underlying financial pressures.

Positives

  • The issuance of warrants incentivized the holders to agree to amendments to the Financing Agreement, potentially indicating improved or stabilized financing terms for Accuray Inc.
  • The warrants include registration rights, which facilitate future liquidity for the holders of the warrant shares.

Negatives

  • The issuance of warrants without separate consideration suggests that Accuray Inc. may have been in a less favorable negotiating position, using equity as an incentive for financing agreement amendments.
  • The exercise of these warrants will result in dilution for existing shareholders.

Risks

  • Potential future dilution of existing shareholders upon the exercise of the 15,467,952 warrants.
  • Restrictions on exercise limit the holder's aggregate voting power or beneficial ownership to 19.9% of the Maximum Voting Power or then outstanding Common Stock, which could impact future capital structure decisions.
  • Shareholder approval is required for certain adjustments to the Exercise Price or number of Warrant Shares that would trigger Nasdaq Rule 5635, potentially delaying or complicating future corporate actions.
  • The Company may delay the filing or suspend the use of a registration statement for up to 120 days in any 12-month period if it would require an Adverse Disclosure or inclusion of unavailable financial statements.

Future Outlook

Accuray Inc. is committed to filing a shelf registration statement (Form S-3 or S-1) within 60 calendar days of the eligible exercise date for the resale of all warrant shares. The company will use commercially reasonable efforts to ensure this registration statement becomes effective and remains effective, facilitating liquidity for the warrant holders.

Industry Context

StockSavvy.ai notes that the issuance of warrants as an incentive for financing agreement amendments is a common practice in situations where a company seeks to secure or adjust debt terms, often reflecting a need for capital or a restructuring of existing obligations. The registration rights provided are standard for significant equity-linked investments, ensuring a clear exit path for the investor.

Comparison to Industry Standards

  • The 19.9% beneficial ownership/voting power restriction is a common covenant to avoid triggering shareholder approval requirements under Nasdaq rules (e.g., Rule 5635) for large equity issuances, which is standard practice to maintain corporate flexibility.
  • The anti-dilution provisions included in the warrants are typical for such instruments, designed to protect the holder's economic interest against certain corporate actions like stock splits or dividends.

Related Party Transactions

  • The issuance of Common Stock Purchase Warrants to TCW Rescue Financing and TCW Direct Lending, which are entities related to The TCW Group, Inc., the reporting person, in connection with amendments to the Financing Agreement.

Stakeholder Impact

  • Shareholders: Potential future dilution upon the exercise of the warrants. The increased beneficial ownership by TCW Group could influence future corporate actions.
  • Creditors (TCW Group entities): Strengthened position through equity upside via warrants, incentivizing their continued support of the financing agreement.

Next Steps

  • Accuray Inc. is obligated to file a shelf registration statement for the resale of the warrant shares within 60 calendar days of the Eligible Exercise Date (for Premium/Super Premium Warrants) or the Issue Date (for Penny Warrants).
  • The Company must use commercially reasonable efforts to ensure the registration statement becomes effective and remains effective.

Key Dates

DateDescription
06/06/2025Date of the original Financing Agreement.
12/11/2025Date of an amendment to the Financing Agreement.
12/12/2025Date of an amendment to the Financing Agreement.
12/15/2025Issue Date for the December Premium Warrants, Super Premium Warrants, and December Penny Warrants, and date of a further amendment to the Financing Agreement.
01/30/2026Date as of which 118,782,630 shares of Common Stock were reported outstanding in the Issuer's Quarterly Report on Form 10-Q.
04/17/2026Date of Event Which Requires Filing of This Statement (Filing Date of Amendment No. 1 to Schedule 13D).
06/16/2026Eligible Exercise Date for December Premium and Super Premium Warrants (six months and one day after Issue Date).
12/15/2032Expiration Date for all December Warrants.

Recommendation

hold

The filing indicates a significant institutional investor, TCW Group, has increased its stake in Accuray Inc. through warrants, suggesting continued confidence in the company's long-term prospects, albeit with terms that favor the investor (warrants as incentive). However, the issuance of warrants without separate cash consideration for the warrants themselves, as a sweetener for financing agreement amendments, could signal underlying financial challenges or a need for capital. The potential for future dilution from warrant exercise is a consideration. Given these mixed signals, a 'hold' recommendation is appropriate, advising investors to monitor the company's operational performance and future financing activities closely.

Keywords

Accuray Inc, TCW Group, Schedule 13D, Common Stock, Warrants, Equity Financing, Beneficial Ownership, Dilution, Registration Rights, SEC Filing, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.